The seriousness of the situation, the differences in regulations from country to country, the difficulty of determining at the start of an incident whether it is a quality problem or a problem of pharmacovigilance, are factors which have to be taken into account.
The seriousness of the situation, the differences in regulations from country to country, the difficulty of determining at the start of an incident whether it is a quality problem or a problem of pharmacovigilance, are factors which have to be taken into account.